4//SEC Filing
Ullem Scott B. 4
Accession 0001225208-25-004942
CIK 0001099800other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:34 PM ET
Size
17.6 KB
Accession
0001225208-25-004942
Insider Transaction Report
Form 4
Ullem Scott B.
CVP, CFO
Transactions
- Tax Payment
Common Stock
2025-05-07$74.92/sh−1,406$105,338→ 27,698 total - Award
Common Stock
2025-05-08+13,400→ 41,098 total - Exercise/Conversion
Common Stock
2025-05-09$45.28/sh+11,250$509,363→ 52,348 total - Award
Performance Rights
2025-05-08+13,400→ 13,400 totalFrom: 2028-05-08→ Common Stock (13,400 underlying) - Sale
Common Stock
2025-05-09$74.40/sh−11,250$837,035→ 41,098 total - Award
Employee Stock Option (Right to Acquire)
2025-05-08+75,200→ 75,200 totalExercise: $74.63From: 2026-05-08Exp: 2032-05-07→ Common Stock (75,200 underlying) - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-05-09−11,250→ 0 totalExercise: $45.28From: 2019-05-17Exp: 2025-05-16→ Common Stock (11,250 underlying)
Holdings
- 266,318(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024.
- [F3]This transaction was executed in multiple trades at prices ranging from $74.12 to $74.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F4]These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
- [F5]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001446989
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:34 PM ET
- Size
- 17.6 KB